TipRanks
Go Ultimate55% OFF

TransCode Therapeutics (RNAZ) Cash flow

TransCode Therapeutics Cash Flow

RNAZ's free cash flow for Q2 2026 was $-5.40M. For the 2026 fiscal year, RNAZ's free cash flow was increased by $0.00 and operating cash flow was $-5.40M. See a summary of the company’s cash flow.

Cash Flow
Cash FlowDec 25Dec 24Mar 24Dec 22Mar 22
$ -19.52M$ -13.34M$ -18.07M$ -15.76M$ -5.27M
$ -4.44K$ -21.76K$ -35.61K$ -100.92K$ -251.82K
$ 31.52M$ 16.40M$ 15.91M$ 5.99K$ 25.52M
$ 17.81M$ 5.81M$ 2.77M$ 4.97M$ 20.83M
$ -19.52M$ -13.36M$ -18.11M$ -15.86M$ -5.52M

Currency in USD

TransCode Therapeutics Cash Flow

-30M-20M-10M010M20M30M40M20182019202020212022202320242025OperatingInvestingFinancing